Molecular Insight Pharmaceuticals realigns to cut costs

01/7/2010 | MarketWire

Molecular Insight Pharmaceuticals, a developer of targeted drugs and imaging radiopharmaceuticals, has announced its plan to eliminate nine positions in order to cut costs and further support its oncology pipeline. The company expects to save about $1 million annually as a result of the move.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC